Priority Date: 14.10.11 (EP 20110185145)

PROCATHEPSIN L AND CATHEPSIN L AS BIOMARKERS FOR ISCHEMIA

  • Application ID: EP12780146
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
Employment test 11 - 50 employees
Company dna cabinet laurent and charras
no operation time available
Headquarter in Lyon and 5 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G01 (MEASURING; TESTING) De Clercq & Partners cvba is specialized in the combination C12 and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Weidner Stern Jeschke, Zacco Denmark A/S, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB and 87 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 14.10.2011 - Priority Date (EP 20110185145)
  • 18.04.2013 - Publication A1 (WO2013053916)
  • 20.08.2014 - Publication A1 (EP2766734)

IPC Classification